Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
17.6% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
20
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.1% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
17
users have liked this narrative
7
users have commented on this narrative
23
users have followed this narrative
9 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
4.7% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
20
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Teladoc Health
AN
AnalystHighTarget
Consensus Narrative from 20 Analysts
Accelerated Digitalization And Aging Trends Will Redefine Virtual Care
Key Takeaways Expanded international offerings and AI-driven care orchestration are set to boost diversification, user retention, and long-term profitability. Enhanced insurance access and a comprehensive care platform position Teladoc to accelerate market share gains amid growing virtual care demand.
View narrative
US$12.00
FV
39.8% undervalued
intrinsic discount
2.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
Global Net Lease
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Urbanization And Last Mile Logistics Will Support Real Asset Stability
Key Takeaways Rapid deleveraging, investment-grade credit, and value-creating share buybacks position the company for margin expansion and stock re-rating. Strategic focus on essential, diversified assets with European exposure enhances risk profile and attracts capital amid growing global real estate demand.
View narrative
US$11.90
FV
34.5% undervalued
intrinsic discount
-16.21%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
Robosense Technology
AN
AnalystHighTarget
Consensus Narrative from 17 Analysts
Autonomous Vehicles And Smart Cities Will Expand LiDAR Markets
Key Takeaways Rapid LiDAR adoption and expanding partnerships in autonomous mobility position Robosense for outsized, recurring revenue growth and multi-vertical market leadership. Technological advances, capital structure improvements, and scaling efficiencies are set to drive sustained margin expansion and long-term earnings upside.
View narrative
HK$63.36
FV
45.5% undervalued
intrinsic discount
65.43%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
NeoGenomics
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
Aging Populations And Digital Health Will Expand Oncology Testing
Key Takeaways Rapid organic growth, strong test validation, and demographic tailwinds position NeoGenomics for sustained revenue and market share gains beyond analyst expectations. Investments in automation, digital pathology, and new service lines could significantly improve margins and free cash flow while diversifying into higher-value offerings.
View narrative
US$12.00
FV
49.2% undervalued
intrinsic discount
10.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
Wave Life Sciences
AN
AnalystHighTarget
Consensus Narrative from 15 Analysts
Digital Transformation And Precision Medicine Will Drive RNA Therapeutics
Key Takeaways Innovative RNA platforms and efficient drug development pipeline position the company for rapid adoption, premium pricing, and structural expansion into high-margin, diversified markets. Lead assets demonstrate best-in-class, differentiated mechanisms with wide-ranging potential, threatening incumbents and setting up for significantly larger revenue streams and earnings growth.
View narrative
US$32.52
FV
70.9% undervalued
intrinsic discount
70.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
Jamf Holding
AN
AnalystHighTarget
Consensus Narrative from 10 Analysts
Apple Device Adoption And Data Privacy Will Transform Endpoint Management
Key Takeaways Deeper integration of security and management solutions, alongside cross-platform support, positions Jamf to capture greater enterprise IT spend as Apple standardization increases. AI-driven operations, major client wins, and a focused go-to-market strategy enhance market share, efficiency, and earnings, promising superior growth and valuation.
View narrative
US$22.95
FV
63.4% undervalued
intrinsic discount
10.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
Sprout Social
AN
AnalystHighTarget
Consensus Narrative from 11 Analysts
Salesforce Integration And Global Social Trends Will Expand Digital Markets
Key Takeaways Rapid upmarket expansion and advanced integrations position Sprout Social for elevated contract values, improved retention, and broad-based, durable revenue growth globally. Unique AI-driven analytics and enhanced compliance tools enable the platform to capture new product categories, expand international reach, and strengthen its competitive moat.
View narrative
US$31.21
FV
53.1% undervalued
intrinsic discount
14.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
Tandem Diabetes Care
AN
AnalystHighTarget
Consensus Narrative from 21 Analysts
Digital Health Integration And Global Expansion Will Elevate Diabetes Care
Key Takeaways Accelerated pharmacy channel adoption, international direct sales, and digital integration could significantly boost revenue, margins, user retention, and free cash flow ahead of expectations. Next-generation automated and tubeless products, combined with a rapidly expanding diabetes market, position Tandem for sustained growth and increased market share.
View narrative
US$47.42
FV
77.5% undervalued
intrinsic discount
9.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
Polestar Automotive Holding UK
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Rising EV Mandates And Battery Breakthroughs Will Transform Global Mobility
Key Takeaways Expansion into new markets and pre-owned sales channels could drive revenue and earnings much higher than currently anticipated by analysts. Strong positioning in EV mandates, premium segments, and technological advancements may lead to faster margin expansion and stable, long-term growth.
View narrative
US$1.50
FV
28.7% undervalued
intrinsic discount
85.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
Value any company in seconds
Popular companies